Cargando…
Newer oral antivirals for COVID-19: Are they the real game changer?
Autores principales: | Kunal, Shekhar, Sakthivel, Pirabu, Malhotra, Nipun, Ish, Pranav |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768019/ https://www.ncbi.nlm.nih.gov/pubmed/35078637 http://dx.doi.org/10.1016/j.hrtlng.2022.01.011 |
Ejemplares similares
-
The emerging threat of multisystem inflammatory syndrome in adults (MIS-A) in COVID-19: A systematic review
por: Kunal, Shekhar, et al.
Publicado: (2022) -
MIS-A after COVID-19: Points to Ponder
por: Ish, Pranav, et al.
Publicado: (2022) -
Plasma therapy in COVID-19: All that glitters is not gold
por: Malhotra, Nipun, et al.
Publicado: (2021) -
Game Changers
Publicado: (2014) -
Game Changers
Publicado: (2014)